Karen A Dawes - Net Worth and Insider Trading
Karen A Dawes Net Worth
The estimated net worth of Karen A Dawes is at least $13 Million dollars as of 2024-11-05. Karen A Dawes is the Director of Repligen Corp and owns about 87,367 shares of Repligen Corp (RGEN) stock worth over $13 Million. Karen A Dawes is the Director of Assertio Holdings Inc and owns about 21,147 shares of Assertio Holdings Inc (ASRT) stock worth over $21,570. Karen A Dawes is also the Director of Barinthus Biotherapeutics PLC and owns about 1,700 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $2,278. Details can be seen in Karen A Dawes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen A Dawes has not made any transactions after 2024-02-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen A Dawes
Karen A Dawes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen A Dawes owns 3 companies in total, including Repligen Corp (RGEN) , PDL BioPharma Inc (PDLI) , and Barinthus Biotherapeutics PLC (BRNS) .
Click here to see the complete history of Karen A Dawes’s form 4 insider trades.
Insider Ownership Summary of Karen A Dawes
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGEN | Repligen Corp | 2024-02-27 | director |
| PDLI | PDL BioPharma Inc | 2008-04-29 | director & Chairperson of the Board |
| BRNS | Barinthus Biotherapeutics PLC | 2021-05-04 | director |
Karen A Dawes Latest Holdings Summary
Karen A Dawes currently owns a total of 3 stocks. Among these stocks, Karen A Dawes owns 87,367 shares of Repligen Corp (RGEN) as of February 27, 2024, with a value of $13 Million and a weighting of 99.81%. Karen A Dawes owns 21,147 shares of Assertio Holdings Inc (ASRT) as of May 8, 2020, with a value of $21,570 and a weighting of 0.17%. Karen A Dawes also owns 1,700 shares of Barinthus Biotherapeutics PLC (BRNS) as of May 4, 2021, with a value of $2,278 and a weighting of 0.02%.
Latest Holdings of Karen A Dawes
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RGEN | Repligen Corp | 2024-02-27 | 87,367 | 145.39 | 12,702,288 |
| ASRT | Assertio Holdings Inc | 2020-05-08 | 21,147 | 1.02 | 21,570 |
| BRNS | Barinthus Biotherapeutics PLC | 2021-05-04 | 1,700 | 1.34 | 2,278 |
Holding Weightings of Karen A Dawes
Karen A Dawes Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen A Dawes has made a total of 20 transactions in Repligen Corp (RGEN) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Repligen Corp is the sale of 1,000 shares on February 27, 2024, which brought Karen A Dawes around $193,350.
According to the SEC Form 4 filings, Karen A Dawes has made a total of 1 transactions in Assertio Holdings Inc (ASRT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Assertio Holdings Inc is the sale of 3,958 shares on May 8, 2020, which brought Karen A Dawes around $12,509.
According to the SEC Form 4 filings, Karen A Dawes has made a total of 1 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the acquisition of 1,700 shares on May 4, 2021, which cost Karen A Dawes around $28,900.
Insider Trading History of Karen A Dawes
- 1
Karen A Dawes Trading Performance
GuruFocus tracks the stock performance after each of Karen A Dawes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen A Dawes is 3.13%. GuruFocus also compares Karen A Dawes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen A Dawes within 3 months outperforms 5 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen A Dawes's insider trading performs compared to the benchmark.
Performance of Karen A Dawes
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.17 | | | | | |
| Relative Return to S&P 500(%) | 1.42 | | | | | |
Karen A Dawes Ownership Network
Ownership Network List of Karen A Dawes
Ownership Network Relation of Karen A Dawes
Karen A Dawes Owned Company Details
What does Repligen Corp do?
Who are the key executives at Repligen Corp?
Karen A Dawes is the director of Repligen Corp. Other key executives at Repligen Corp include director & Chief Executive Officer Anthony Hunt , Senior VP & R&D Ralf Kuriyel , and SVP & Global Operations & IT James Bylund .
Repligen Corp (RGEN) Insider Trades Summary
Over the past 18 months, Karen A Dawes made 2 insider transaction in Repligen Corp (RGEN) with a net sale of 1,850. Other recent insider transactions involving Repligen Corp (RGEN) include a net sale of 56,970 shares made by Anthony Hunt , a net sale of 15,130 shares made by Ralf Kuriyel , and a net purchase of 3,115 shares made by Martin D Madaus .
In summary, during the past 3 months, insiders sold 22,191 shares of Repligen Corp (RGEN) in total and bought 0 shares, with a net sale of 22,191 shares. During the past 18 months, 84,111 shares of Repligen Corp (RGEN) were sold and 6,315 shares were bought by its insiders, resulting in a net sale of 77,796 shares.
Repligen Corp (RGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Repligen Corp Insider Transactions
Karen A Dawes Mailing Address
Above is the net worth, insider trading, and ownership report for Karen A Dawes. You might contact Karen A Dawes via mailing address: 579 Bellevue Ave, Newport Ri 02840.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
